{
 "name": "懷特",
 "slug": "tw-4108",
 "aliases": [
  "懷特生技新藥股份有限公司",
  "PhytoHealth",
  "4108"
 ],
 "ticker": "4108",
 "industry": "生技醫療業",
 "website": "www.phytohealth.com.tw",
 "summary": "懷特（4108）是上市的生技醫療類股公司，1998 年成立，2008 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "懷特生技新藥股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "PhytoHealth",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "2008-07-16",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "1998-11-24",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "李伊俐",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "李伊伶",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 1986188790,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安永聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "www.phytohealth.com.tw",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 11855,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-當月營收；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": -31.84,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-去年同月增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 5.34,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：累計營業收入-前期比較增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "管線：PG2（懷特血寶）",
   "value": "癌因性疲憊症｜已獲TFDA藥證並上市｜台灣",
   "unit": "",
   "as_of": "2025-09-02",
   "source": "https://www.phytohealth.com.tw/uploads/images/IR/2025/1140902%E6%87%B7%E7%89%B9%E6%B3%95%E4%BA%BA%E8%AA%AA%E6%98%8E%E6%9C%83%E7%B0%A1%E5%A0%B1(%E4%B8%AD%E6%96%87%E7%89%88).pdf",
   "note": "保留2025-09-02法說快照；未把FDA IND許可當成上市藥證。"
  },
  {
   "claim": "管線：PHN131（懷特痛寶／Oraphine；nalbuphine）",
   "value": "中到重度疼痛｜已獲TFDA藥證並上市｜台灣",
   "unit": "",
   "as_of": "2025-09-02",
   "source": "https://www.phytohealth.com.tw/uploads/images/IR/2025/1140902%E6%87%B7%E7%89%B9%E6%B3%95%E4%BA%BA%E8%AA%AA%E6%98%8E%E6%9C%83%E7%B0%A1%E5%A0%B1(%E4%B8%AD%E6%96%87%E7%89%88).pdf",
   "note": "保留2025-09-02法說快照；FDA核准執行不等於試驗在美國進行。PHN131與nalbuphine對照另見官網產品頁 https://www.phytohealth.com.tw/en/pipeline 。"
  },
  {
   "claim": "管線：PHN031（懷特骨寶）",
   "value": "預防骨質疏鬆症｜已完成FDA核准之Phase IIa試驗｜試驗地區未在簡報揭露",
   "unit": "",
   "as_of": "2025-09-02",
   "source": "https://www.phytohealth.com.tw/uploads/images/IR/2025/1140902%E6%87%B7%E7%89%B9%E6%B3%95%E4%BA%BA%E8%AA%AA%E6%98%8E%E6%9C%83%E7%B0%A1%E5%A0%B1(%E4%B8%AD%E6%96%87%E7%89%88).pdf",
   "note": "保留2025-09-02法說快照；未把FDA IND許可當成上市藥證。"
  },
  {
   "claim": "管線：PHN033（懷特糖寶）",
   "value": "糖尿病腎病變｜已完成FDA核准之Phase IIa試驗｜試驗地區未在簡報揭露",
   "unit": "",
   "as_of": "2025-09-02",
   "source": "https://www.phytohealth.com.tw/uploads/images/IR/2025/1140902%E6%87%B7%E7%89%B9%E6%B3%95%E4%BA%BA%E8%AA%AA%E6%98%8E%E6%9C%83%E7%B0%A1%E5%A0%B1(%E4%B8%AD%E6%96%87%E7%89%88).pdf",
   "note": "保留2025-09-02法說快照；未把FDA IND許可當成上市藥證。"
  },
  {
   "claim": "管線：PG2合併療法（懷特血寶）",
   "value": "癌症｜啟動Phase II合併療法研究｜地區未在簡報揭露",
   "unit": "",
   "as_of": "2025-09-02",
   "source": "https://www.phytohealth.com.tw/uploads/images/IR/2025/1140902%E6%87%B7%E7%89%B9%E6%B3%95%E4%BA%BA%E8%AA%AA%E6%98%8E%E6%9C%83%E7%B0%A1%E5%A0%B1(%E4%B8%AD%E6%96%87%E7%89%88).pdf",
   "note": "保留2025-09-02法說快照；未把FDA IND許可當成上市藥證。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-4108.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}